June 19, 2013
The settlement comes after a nearly 10-year legal battle in which Pfizer and Nycomed (now part of Takeda) sought to enforce the patent for its blockbuster acid reflux medicine.
|
June 19, 2013
By:
Patricia Van Arnum
The move follows rejection of Elan shareholders of certain key deals and withdrawal of Royalty Pharma bid.
|
June 19, 2013
The billion-dollar deal provides strengthens J&J’s oncology portfolio.
|
June 19, 2013
The multimillion investment in a facility in Cambridge is part of the company’s move to create strategic global R&D centers in the UK, US and Sweden.
|
June 19, 2013
A proposed deal with Aspen includes the company’s site in Notre-Dame-de-Bondeville, France.
|
June 14, 2013
The US Supreme Court ruled that naturally occurring isolated biological material is not patentable, but a synthetic version of gene material may be patented.
|
June 14, 2013
Cobra Biologics announced several product development projects with Novolytics, Recopharma, and Vaccibody.
|
June 12, 2013
ISPE study reveals quality systems of manufacturing as the leading cause of drug shortages.
|
June 11, 2013
One employee is dismissed, another has resigned, and three others are put on administrative leave.
|
|
